Prescription Drug Coverage: Why You're Overpaying and How to Fix It

Prescription drug coverage is notoriously complex and expensive. For employers, it's one of the costliest parts of healthcare benefits: U.S. retail prescription drug spending reached $467 billion in 2024, up 7.9% from the year before. The traditional system relies on a middleman called a Pharmacy Benefit Manager (PBM). The PBM sits between the employer, the health plan, and the drug companies, and its revenue is often tied to a drug's list price, so a higher list price can mean a bigger rebate for the PBM. The incentives run in the wrong direction. WellthCare™ replaces opaque PBMs with transparent, aligned pricing.

In most employer plans, prescription drug benefits are "carved out" or integrated into the medical plan. You pay a co-pay at the pharmacy, and the employer pays a negotiated rate to the PBM. But the PBM often charges the employer more than it pays the pharmacy, a practice called "spread pricing." The difference goes into the PBM's pocket, so costs go up for everyone and health outcomes don't improve. WellthCare, a health-to-wealth benefit system with transparent, aligned pharmacy pricing, rewards employees for preventive actions and medication adherence with store dollars and automatic retirement contributions, typically saving employers 20-40% on drug costs.

How Prescription Drug Coverage Typically Works

In a typical employer-sponsored plan, the flow works like this:

1. Formulary Design: The PBM creates a list of covered drugs, sorted by cost tier (generic, brand, specialty). Higher tier means higher co-pay for you.
2. Rebate Negotiations: PBMs negotiate rebates from drug manufacturers to get their drugs on preferred tiers. Rebates are often calculated as a percentage of a drug's list price, which rewards steering patients toward higher-priced drugs and can push lower-cost alternatives off the formulary.
3. Pharmacy Network Access: You fill prescriptions at pharmacies in the PBM's network. The PBM controls the pricing.
4. Claims Processing: The PBM processes the claim, applies your co-pay, and bills the employer for the rest, minus any rebates it keeps.

What Goes Wrong with Traditional Coverage

• No Transparency: Employers don't know the true cost of a drug after rebates. They can't audit the PBM's performance.
• Wrong Incentives: PBMs profit from higher list prices, so they have no reason to lower overall spend.
• Employee Confusion: Complicated formularies, prior authorizations, and step therapy make it hard to get the medicine you need.
• Low Adherence: When costs are high or processes are confusing, people skip doses or abandon prescriptions. That worsens health outcomes and drives up long-term claims.

FTC and State Actions Against Spread Pricing

These practices are now drawing government action. In July 2024, the FTC published an interim staff report finding that PBMs and drug manufacturers sometimes agree to keep lower-cost drugs off formularies in exchange for larger rebates. Congressional investigators found rebates are frequently calculated as a percentage of a drug's list price, which rewards steering patients toward higher-priced drugs. A January 2025 FTC report estimated the three largest PBMs' spread-pricing income at $1.4 billion and documented heavy markups on specialty generic drugs. In September 2024, the FTC sued Caremark, Express Scripts, and OptumRx over rebating practices it alleges inflated insulin list prices and blocked cheaper alternatives. The first settlement arrived in February 2026, when Express Scripts agreed to give plan sponsors a standard option to move off rebate guarantees and spread pricing, to delink its manufacturer compensation from list prices, and to report drug-level pricing. All 50 states have also passed laws regulating PBMs, with Arkansas going furthest in 2025 by barring PBMs from owning retail pharmacies.

A Smarter Way: Transparent Pharmacy Benefits

Smart employers are moving away from the traditional PBM model toward transparent, aligned systems. WellthCare Pharmacy™ is a prime example. Instead of making money from spread pricing, WellthCare uses a cost-plus transparent model: the plan pays the pharmacy's actual drug acquisition cost plus a flat dispensing fee, with no hidden spread. That approach integrates directly with employees' plans of care, so medication adherence is tied to preventive health actions, not just co-pays.

In the WellthCare ecosystem, prescription drug coverage becomes part of a Health-to-Wealth benefit system. Employees get:

• Personalized medication reminders via the WellthCare app, improving adherence.
• Automatic refills aligned with their plan of care, reducing waste.
• Transparent pricing with no hidden fees or spread games.
• Earned store dollars for healthy behaviors, including taking medications as prescribed.

How WellthCare Transforms the Prescription Drug Experience

WellthCare reimagines prescription drug coverage in four steps:

1. Prevention First: Employees take preventive actions (scans, labs, adherence) to earn real dollars at the WellthCare Store™, spendable on FSA-approved, health-supporting products, before they ever need a prescription.
2. Integrated Pharmacy: WellthCare Pharmacy™ becomes the pharmacy of record, replacing the PBM with aligned pricing that typically cuts drug costs 20-40%.
3. Data-Driven Insights: The WellthCare Readiness Index™ analyzes actual medication use and benchmarks it against transparent pricing, showing employers, with their own data, how much they can save.
4. Continuous Engagement: Employees get alerts to take and re-order meds. That keeps them adherent and healthy while reducing employer claim exposure.

Why This Matters for Employers

Employers who adopt aligned prescription drug coverage see fewer claims, lower costs, and higher employee satisfaction. The traditional PBM model is a black box of hidden fees and wrong incentives. WellthCare's approach turns pharmacy benefits into a transparent system, and program savings fund automatic retirement contributions alongside the store rewards employees earn.

Prescription drug coverage doesn't have to be a cost center stuck in an opaque system. A transparent, integrated, and incentive-aligned model lets employers reduce drug spend, improve adherence, and give employees a reason to take their medication, because it pays them back.